Does Medicare Part D Cover Wegovy for Weight Loss? 2026 Criteria

If you’re a Medicare beneficiary asking whether Part D will cover Wegovy for weight management, the answer depends entirely on your cardiovascular history. Below we explain the 2026 cardiovascular disease criteria, what qualifies, expected costs, and options for beneficiaries who don’t meet the strict requirements.

Medicare’s 2026 Wegovy Coverage

What you need to know first: Medicare Part D covers Wegovy only for cardiovascular risk reduction in patients with established atherosclerotic cardiovascular disease (ASCVD). It does not cover Wegovy for weight loss alone.

The door opened when the FDA approved semaglutide 2.4 mg (Wegovy) for reducing the risk of major adverse cardiovascular events (MACE) in adults with heart disease combined with excess weight. The federal government agreed that this cardiovascular indication made Wegovy eligible under Part D’s drug benefit.

How it works:

• If you have documented ASCVD: Wegovy can be authorized through your Part D plan
• For obesity alone: ineligible — Medicare’s statutory exclusion of anti-obesity drugs still applies
• Specific plans may or may not include it for the CVD indication — not all plans have added it

Cardiovascular Disease Criteria

You must meet all of these requirements:

Required — documented ASCVD including at least one of:

• Prior myocardial infarction — verified by troponin levels and ECG
• Prior stroke — documented neurological event
• Documented peripheral vascular disease — confirmed by ankle-brachial index <0.9, angiography, or revascularization history

Plus: BMI ≥ 27 with the cardiovascular condition

What doesn’t count:

• Imaging findings without clinical events
• High blood pressure or cholesterol by themselves
• Heart failure without atherosclerotic disease
• High BMI alone
• Metabolic syndrome

Research indicates that approximately 1 in 8 overweight seniors have the required ASCVD history.

What You’ll Pay

When covered under the cardiovascular indication:

The Inflation Reduction Act: the $2,000 annual out-of-pocket maximum for Part D limits your total exposure. After reaching the annual cap, Wegovy has zero additional copay.

Manufacturer savings cards are not allowed for Medicare beneficiaries — government plan members cannot use manufacturer coupons.

PA Process for Medicare

Medicare Part D PA requirements for Wegovy involve:

1. ASCVD documentation: Complete cardiovascular history confirming qualifying ASCVD events
2. Anthropometric data: Height and weight from a recent visit
3. Ongoing cardiac care: Documentation that Wegovy is being prescribed as part of a holistic cardiac treatment approach
4. Ordering physician: Certain Part D formularies require the prescription to come from or be supported by a cardiologist

Processing: 1-3 business days standard; 24 hours expedited. Medicare mandates faster turnaround than commercial plans.

Appeal Rights for Medicare Beneficiaries

Federal law provides robust appeal rights:

1. Redetermination: File within 60 days — decided within 72 hours expedited
2. IRE reconsideration: Automatic if Level 1 fails — decided within 7 days
3. Level 3: A judicial hearing — if the claim exceeds approximately $200
4. Medicare Appeals Council and Level 5: Additional review levels

Each level has strict deadlines. Getting help from a benefits counselor to ensure proper filing.

Don’t meet the CVD criteria? Compounded semaglutide is available from licensed US telehealth providers for $199/month without insurance.

See Also

• Medicare Part D Ozempic — covered for diabetes only
• Medicare Part D Mounjaro — tirzepatide for diabetes
• Medicare Part D Zepbound — tirzepatide for obesity (extremely limited coverage)
• Medicare Part D Rybelsus — oral semaglutide for diabetes
• Kaiser Wegovy Coverage — Kaiser’s specific Medicare Advantage policies

Frequently Asked Questions

Does Medicare Part D cover Wegovy for weight loss?

Only with cardiovascular disease. Medicare Part D covers Wegovy solely for cardiovascular risk reduction in patients with documented ASCVD. The anti-obesity use remains excluded.

What cardiovascular conditions qualify for Medicare Wegovy coverage?

Documented prior myocardial infarction, stroke, or peripheral artery disease. Risk factors like hypertension or diabetes alone do not qualify.

How much does Wegovy cost on Medicare Part D?

Costs vary by coverage phase $200-$500/month during initial coverage, dropping to near zero in catastrophic coverage. The $2,000 annual cap provides financial protection.

Disclaimer: This article is for informational purposes only and does not constitute medical or insurance advice. Medicare coverage policies are complex and change annually. Consult your healthcare provider and your Medicare Part D plan for personalized guidance.